NeurogesX
Develops and commercializes therapies for chronic peripheral neuropathic pain.
Employees
Enterprise value
$4—6m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
SV Health Investors(exited)
Alta Partners(exited)
ARCH Venture Partners(exited)
Global Life Science Ventures(exited)
Walden International(exited)
Montreux Equity Partners(exited)
Diamond Capital Management(exited)
TIAA(exited)
GroveStreet(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.